This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Other key personnel changes across the Pacific Northwest tech industry: Rick Pittenger is now chieftechnologyofficer of Seattle health tech startup DexCare. Pittinger was previously chieftechnologyofficer at analytics company Lucid, which was acquired by digital market research company Cint last year for about $1.1
Adaptive Photo) — Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies , the company said today in a regulatory filing. He was first hired by Adaptive as chieftechnologyofficer. Sana Biotechnology named two new research leaders. Mark Adams.
Sana Biotechnology CEO Steve Harr cuts the ribbon at the company’s new manufacturing facility in Bothell, Wash., Suzan DelBene, Bothell Mayor Mason Thompson, and Sana CTO Snehal Patel also participated in the ceremony. Sana Biotechnology CEO Steve Harr outside the company’s new manufacturing facility in Bothell, Wash.,
Selvan Senthivel, chieftechnologyofficer for Symbl. Selvan Senthivel is the new chieftechnologyofficer for the 6-year-old Seattle startup. Senthivel was most recently CTO for GE HealthCare and was previously part of AI engineering leadership at Amazon Web Services, among other roles.
Adaptive Biotechnologies). Adaptive Biotechnologies has promoted one exec, while another is departing next month. Adams joined the Seattle biotech giant last year as CTO. He also served as chief information officer at biotech companies Celmatix and Good Start Genetics. Mark Adams. Mark Adams is now COO.
MagniX’s chieftechnologyofficer, Riona Armesmith, works on electric propulsion systems like the one in the background at the company’s headquarters in Everett, Wash. ” As MagniX’s chieftechnologyofficer, Armesmith loves to dive into the nuts and bolts of electric aviation.
F5 Chief People Officer Lyra Schramm (left) and ChiefTechnologyOfficer Kunal Anand. (F5 F5 Photos) — Seattle-based application security and delivery giant F5 announced two new executive appointments this week: Lyra Schramm , the company’s new chief people officer, and Kunal Anand , chieftechnologyofficer.
The founding team includes: • CEO Peter Horadan, previously EVP of engineering and CTO at tax automation startup Avalara. Chief Strategy Officer Matthew Shanahan , previously chief operating and innovation officer at Globys, a software company offering digital billing products. Nautilus Biotechnology Photo).
Ryan Crisman , a veteran of ZymoGenetics, Juno Therapeutics, and Gates Biomanufacturing Facility who is Umoja’s CTO. ” Umoja is one of several companies in the Seattle region developing immunotherapy-related technologies. co-founder and managing director of MPM Capital, said in a statement. .”
Bring the whole organization on the AI journey CIOs also see the need to bring everyone along on that AI journey, something that takes a well-articulated narrative about the benefits AI can bring to those who are and will be impacted by the technology. That’s the case for Yi Zhou, CTO and CIO with Adaptive Biotechnologies.
Also in January, South Koreas government announced an $88 million investment to drive the use of synthetic data in the biotechnology industry. The company uses synthetic data to create a massive coding training ground allowing its AI models to focus on complex coding tasks, says Eiso Kant, CTO and co-founder.
Yang is a biotech vet who worked at Adaptive Biotechnologies, AstraZeneca, and Genentech before joining the Allen Institute, a Seattle-based nonprofit founded almost 20 years ago by Paul Allen, the late Microsoft co-founder. He’ll lead Qumulo’s engineering teams alongside CTO Kiran Bhageshpur, who joined earlier this year.
Seattle-based Adaptive Biotechnologies announced Nitin Sood as its first-ever chief commercial officer. He was previously CEO of NuGen Technologies and Boreal Genomics. . Based in India, Muthegere will be the site leader for Ally.io’s offices in Chennai and Bengalaru. Nitin Sood. Adaptive Biotech Photo).
Chad Whalen is now chief revenue officer. Kunal Anand is now chieftechnology and AI officer. He was previously chieftechnologyofficer. Sana Biotechnology, and Indiana University’s Kelley School of Business. Whalen was previously executive vice president of worldwide sales.
It acquired Adaptive Technology Group in 2019. Adaptive Biotechnologies Corporation disclosed in a SEC filing that Leslie Trigg is voluntarily resigning from the company’s board. based startup Smarsh named Vinay Mehta as its new CTO. He previously worked as CTO and information officer at customer loyalty company cxLoyalty.
He’s now CEO of Nautilus Biotechnology, and he’s not taking any big chances in the current economic downturn. In Washington, Absci , Zymeworks , TwinStrand Biosciences , NanoString Technologies and Sana Biotechnology all shed employees in 2022. Sonoma chieftechnologyofficer Heidi Hagen. Nautilus Photo).
The news is a bright spot for Seattle’s biopharma scene which has seen employee cuts at several biotech companies recently as part of wider layoffs in the industry, including at NanoString Technologies , Sana Biotechnology , Eliem Therapeutics and Neoleukin Therapeutics.
The finalists are: Adaptive Biotechnologies prices IPO at $20 per share. This pioneering health, life science, biotechnology or medical breakthrough holds great promise for making the lives of people better or improving the health care system. Sana Biotechnology. Michael Petrochuk, co-founder and CTO of WellSaid Labs.
That list dropped by three last year when Remitly and Sana Biotechnology completed their initial public offerings and Auth0 sold to Okta for $6.5 Helion co-founder and ChiefTechnologyOfficer Chris Pihl (left) with founder and CEO David Kirtley at their facility in Redmond, Wash. Valuation : $3.96 billion (as of Sept.
He was previously executive vice president of engineering and CTO at tax software giant Avalara, and also led teams at Microsoft and Concur. Other key personnel changes across the Pacific Northwest tech ecosystem: Dhaval Patel, chief scientific officer at Sana. The company is ranked No.
Co-founder and CEO : Nick Huzar, former product manager at T-Mobile and CTO at Konnects. Sana Biotechnology. GeekWire story from March 2020 : OfferUp raises $120M, will acquire rival Letgo; OLX Group to own 40% of combined entity. Valuation : $1.4 billion (as of August 2019). GeekWire 200 rank : No. Founded : 2011. GeekWire Photo).
The technology was developed under DARPA’s Reliable Neural-Interface Technology (RE-NET) program , and offers new potential for safely expanding the use of brain-machine interfaces (BMIs) to treat physical disabilities and neurological disorders.
based vacation rental platform Vacasa added two new independent directors to its board : former HomeAdvisor CEO Chris Terrill , and Adaptive Biotechnologies CFO Chad Cohen. Human resources technology company Limeade hired Padmashree Koneti as VP of product and Julie Nyberg as VP of people. (Vacasa Photos). Portland, Ore.-based
The five finalists for the Health Innovation of the Year at the GeekWire Awards highlight the multitude of ways that technology is changing healthcare, from treatment in the hospital to the development of new therapeutics. Read more about the finalists and cast your vote below. The company, which raised $22.4
Other finalists: Rec Room; Group 14 Technologies; SeekOut; and iSpot. Workplace of the Year, presented by JLL Winner: Adaptive Biotechnologies Francis Lo, chief people officer at Adaptive Biotechnologies, accepts the Workplace of the Year Award at the 2023 GeekWire Awards. Impinj went public in 2016.
“Preeti is an exceptionally talented engineering leader,” Temporal CTO and co-founder Samar Abbas said in a statement. Nitin Sood , chief commercial officer of the MRD business at Adaptive Biotechnologies, is departing. She also held vice president roles at Yahoo, VMWare, and Oracle.
Former Microsoft Dynamics 365 CTO Sri Srinivasan joined Redwood, Calif.-based based Zuora as chief product and engineering officer. Other recent Tech Moves from across the Pacific Northwest: Seattle-based AVM Biotechnology appointed Manon Cox as its new CEO and Gary Grohmann as chief regulatory officer.
Auth0 was co-founded in 2013 by Eugenio Pace , who formerly ran the patterns and practices group at Microsoft, and Matias Woloski , a software engineer who remains the company’s CTO. Other finalists: Accolade; Athira Pharma; Rover; and Sana Biotechnology. Winner: Adaptive Biotechnologies. Winner: Rad Power Bikes.
Adaptive Biotech Photo) — Seattle biotech company Adaptive Biotechnologies Corp. He previously worked as VP and general manager at Lithium Technologies. Kyle Mathews , CTO of web experiences platform Gatsby, wrote in a LinkedIn post that he is relocating to Seattle. Kevin Conroy.
Other finalists: Kwame Boler & Claudius Mbemba, co-founders of NEU; Michael Petrochuk, co-founder and CTO of WellSaid Labs; Aran Khanna, co-founder and CEO of Reserved.ai; Tony Huang, co-founder and CEO of Possible Finance. Other finalists are: Adaptive Biotechnologies prices IPO at $20 per share; Assurance acquired by Prudential for $2.35
Juno veterans went on to start or fill leadership positions at Sana Biotechnology, Lyell Immunopharma, Umoja Biopharma, Shape Therapeutics, GentiBio, Eliem Therapeutics, Genemod, Century Therapeutics, Silverback Therapeutics, Tune Therapeutics, Affini-T Therapeutics, and others. Sana Biotechnology. Photo courtesy of William Canestaro).
Helping people in all stages Now, Pultz is the chieftechnologyofficer at Mopac, another company born from the IPD and UW ingenuity. She was on the forefront of the biotechnology future. KumaMax is currently in phase two of clinical trials, meaning it’s one step closer to making gluten intolerance less intolerable.
Adaptive Biotechnologies Photo). Chad Cohen will step down as CFO of Adaptive Biotechnologies on Feb. Principal accounting officer Kyle Piskel will serve as interim CFO after Cohen resigns. Sirosh is currently CTO of real estate platform company Compass. Chad Cohen. Joseph Sirosh (Compass Photo). Vancouver, Wash.-based
Younger founded the company in 2017 with CTO Randolph Lopez using the technology they helped to develop while graduate researchers at the UW’s Institute for Protein Design. The drug development platform company combines computational tools with yeast experiments to identify potentially therapeutic proteins.
Others include Strella Biotechnology , Shelf Engine , and iFoodDS. The team includes: CTO Sunil Koduri , who spent nearly 20 years as a manager at Microsoft. Is it being kept cold-chain compliant like the truck driver or warehouse swears it is?” The company has five employees and four advisors.
But the potential market is vast, Cyrus Biotechnology CEO Lucas Nivon told GeekWire. From left: Outpace CEO Marc Lajoie, senior scientist Bobby Langan and CTO Scotty Boyken. Proteins have the ability to fold into shapes that can precisely target biological molecules. After all, proteins are built from an alphabet of 20 amino acids.
Allen School of Computer Science & Engineering; Oren Etzioni, CEO of the Allen Institute for AI; Leslie Alexandre, President and CEO of Life Science Washington; Leen Kawas, CEO of Athira Pharma; Peter Lee, CVP of Research and Incubations at Microsoft; Caroline Lewis, partner at Rogue Venture Partners; and Saad Bashir, CTO for City of Seattle.
We organize all of the trending information in your field so you don't have to. Join 83,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content